Projet ARISTOS (Horizon Europe, appel à projets 2021)
Action : Cofund Postdoctoral programme
Statut du projet : SIGNED

ARISTOS aims to be the next Postdoctoral Program in Biomedicine and Health Sciences cofunded by the Horizon Europe Marie Skłodowska-Curie COFUND scheme and the Consorcio Centro de Investigación Biomédica en Red M.P. (CIBER) in Spain. With a total duration of 60 months, it will offer 27 postdoctoral positions for three years each, at CIBER groups led by distinguished principal investigators. Through an open and merit-based recruitment procedure, it will provide excellent opportunities for international, intersectoral and interdisciplinary research and training under attractive working conditions. CIBER is a public research consortium that embraces 511 research groups which belong to more than 100 different Affiliated Institutions (universities, research centers and hospitals) around Spain. It is currently employing more than 800 researchers and clusters some of the most important facilities of biomedicine research in Spain directly participating in more than 17 technology and research platforms. As a network of excellence is tasked with being a reference in research and innovation in Spain and internationally. Fellows participating in the ARISTOS Program will have the opportunity to carry out a research project in on a topic related with disease prevention, diagnosis, monitoring, and treatment and come closer to the private sector by collaborating with medical and healthcare companies during their secondments or special events like the Entrepreuners Dissemination Days. Beyond the Fellows' training through their own research, the ARISTOS Program will also provide to the Fellows career enhancing opportunities through training courses in research techniques, complementary workshops for transferable skills, scientific meetings and conferences and the access to international scientific and clinical networks, with the final aim to promote knowledge exchange and the mobility among the academic, clinical and private sectors.

Mots clés : biomedicine bioengineering nanomedicine biomaterials oncology obesity diabetes cardiovascular, respiratory, neurodegenerative, infectious and rare diseases mental health epidemiology

Participants :
- Nanomol technologies sl (Espagne) — Partner, associated partner, Organismes privés (hors enseignement), subvention : 0.0 €
- Barcelona liver bioservices sl (Espagne) — Partner, associated partner, Organismes privés (hors enseignement), subvention : 0.0 €
- Viscofan sa (Espagne) — Partner, associated partner, Organismes privés (hors enseignement), subvention : 0.0 €
- Atlas molecular pharma sl (Espagne) — Partner, associated partner, Organismes privés (hors enseignement), subvention : 0.0 €
- Fundacion md anderson international espana (Espagne) — Partner, associated partner, Recherche, subvention : 0.0 €
- Qubiotech health intelligence sl (r.m.a coruna) (Espagne) — Partner, associated partner, Organismes privés (hors enseignement), subvention : 0.0 €
- Biomedical Research Networking Center on Neurodegenerative Diseases (Espagne) — Coordinator, beneficiary, Recherche, subvention : 3868560.0 €
- Greendecision srl (Italie) — Partner, associated partner, Organismes privés (hors enseignement), subvention : 0.0 €
- Nanoligent s.l. (Espagne) — Partner, associated partner, Organismes privés (hors enseignement), subvention : 0.0 €
- Resonant circuits limited (Royaume-Uni) — Partner, associated partner, Organismes privés (hors enseignement), subvention : 0.0 €
- BioNanoNet (Autriche) — Partner, associated partner, Recherche, subvention : 0.0 €